PD-1 expression on CD4⁺ T cells before and after treatment with abatacept. PD-1 expression on CD4⁺ T cells was assessed via flow cytometry at baseline and after 6 doses of abatacept treatment. There was a decrease in PD-1 expression by CD4+ T cells after treatment with abatacept (P = .0028).